Then, we confirmed that the overexpression of miR‐194‐3p could inhibit the proliferation, migration, and invasion of breast cancer cells and downregulate the protein level of MECP2, and the restoration of miR‐194‐3p expression could reduce the linc‐ROR‐mediated promotion of breast cancer progression. This evidence concerns the gene MECP2 and breast carcinoma.